FUCHS HENRY J 4
4 · BIOMARIN PHARMACEUTICAL INC · Filed Mar 17, 2023
Insider Transaction Report
Form 4
FUCHS HENRY J
Chief Medical Officer
Transactions
- Award
Common Stock
2023-03-15+16,840→ 228,986 total - Tax Payment
Common Stock
2023-03-15$87.74/sh−4,799$421,064→ 224,187 total - Tax Payment
Common Stock
2023-03-16$93.41/sh−36,000$3,362,760→ 188,187 total - Award
Stock Option (Right to buy Common Stock)
2023-03-15+38,450→ 38,450 totalExercise: $87.74From: 2024-03-15Exp: 2033-03-14→ Common Stock (38,450 underlying)
Footnotes (2)
- [F1]Restricted stock units granted on March 15, 2023. Price not applicable.
- [F2]Option grant vests 12/48th on March 15, 2024 and 1/48th on the 15th day of each month thereafter.